Description
Background:
Veltuzumab is a monoclonal antibody that targets the CD20 protein found on the surface of B cells. It is similar to another antibody called rituximab, which is widely used in the treatment of various B-cell malignancies and autoimmune disorders.
Veltuzumab is designed to selectively bind to CD20-positive B cells and trigger their destruction through various mechanisms, including antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). By depleting B cells, veltuzumab aims to modulate the immune response and potentially provide therapeutic benefits in conditions where abnormal B cell activity is involved.Veltuzumab is a monoclonal antibody which is being investigated for the treatment of non-Hodgkin’s lymphoma.
Intended Use:
For Estimation of Veltuzumab in human serum and plasma. Please note the kit has not been optimized to be used for any other animal species. Should you require a specific sera tested, please connect with us at sales@krishgen.com for optimization.
If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!